Palifermin in allogeneic HSCT: many questions remain.

MLA

van der Velden, W. J. F. M., et al. “Palifermin in Allogeneic HSCT: Many Questions Remain.” Bone Marrow Transplantation, vol. 43, no. 1, Jan. 2009, pp. 85–86. EBSCOhost, https://doi.org/10.1038/bmt.2008.269.

APA

van der Velden, W. J. F. M., Herbers, A. H. E., & Blijlevens, N. M. A. (2009). Palifermin in allogeneic HSCT: many questions remain. Bone Marrow Transplantation, 43(1), 85–86. https://doi.org/10.1038/bmt.2008.269

Chicago

van der Velden, W J F M, A H E Herbers, and N M A Blijlevens. 2009. “Palifermin in Allogeneic HSCT: Many Questions Remain.” Bone Marrow Transplantation 43 (1): 85–86. doi:10.1038/bmt.2008.269.